Mumps

  • Sandra J. Holmes
Chapter

Abstract

Mumps is an acute contagious disease caused by a para-myxovirus. Infection with the mumps virus typically results in unilateral or bilateral parotitis. However, parotitis may be absent with only nonspecific or respiratory symptoms present, or the infection may be asymptomatic. Serious complications are rare.

Keywords

Aseptic Meningitis Mumps Virus Acute Viral Infection Mumps Vaccine Mumps Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adair, C. V., Gauld, R. L., And Smadel, J. E., Aseptic meningitis, a disease of diverse etiology: Clinical and etiologic studies on 854 cases, Ann. Intern. Med. 39: 675–704 (1953).PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson, D. M., And Hutchinson, D. N., Renal damage and virus infection, Br. Med. J. 3: 680–681 (1968).PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson, R. M., Crombie, J. A., And Grenfell, B. T., The epidemiology of mumps in the UK: A preliminary study of virus transmission, herd immunity and the potential impact of immunization, Epidemiol. Infect. 99: 65–84 (1987).PubMedCrossRefGoogle Scholar
  4. 4.
    Arday, D. R., Kaniarpane, D. D., And Kelley, P. W., Mumps in the US Army 1980–1986: Should recruits be immunized? Am. J. Public Health 79: 471–474 (1989).PubMedCrossRefGoogle Scholar
  5. 5.
    Arita, M., Ueno, Y., And Masuyama, Y., Complete heart block in mumps myocarditis, Br. Heart J. 46: 342–344 (1981).PubMedCrossRefGoogle Scholar
  6. 6.
    Arroyo, M., Alia, J. M., Mateos, M. L., Carrasco, J. L., Ballesteros, F., Lardinois, R., And The Paediatric Collaborative Group, Natural immunity to measles, rubella and mumps among Spanish children in the pre-vaccination era, Int. J. Epidemiol. 15: 95–100 (1986).Google Scholar
  7. 7.
    AzImi, P. H., Cramblett, H. G., And Haynes, R. E., Mumps meningoencephalitis in children, J.A.M.A. 207: 509–512 (1969).CrossRefGoogle Scholar
  8. 8.
    Balfour, H. H., JR., And Amren, D. P., Rubella, measles and mumps antibodies following vaccination in children: A potential rubella problem, Am. J. Dis. Child. 132: 573–577 (1978).PubMedGoogle Scholar
  9. 9.
    Banatvala, J. E., Bryant, J., Schernthaner, G., Borkenstein, M., Schuber, E., Brown, D., Desilva, L. M., Menser, M. A., And Slunk, M., Coxsackie B, mumps, rubella and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia, Lancet 1: 1409–1412 (1985).Google Scholar
  10. 10.
    Bang, H. O., And Bang, J., Involvement of the central nervous system in mumps, Acta Med. Scand. 113: 487–505 (1943).CrossRefGoogle Scholar
  11. 11.
    Beard, C. M., Benson, R. C., JR., Kelalis, P. P., Elveback, L. R., And Kurland, L. T., The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1934 to 1974, Mayo Clin. Proc. 52: 3–7 (1977).PubMedGoogle Scholar
  12. 12.
    Beardwell, A., Facial palsy due to the mumps virus, Br. J. Clin. Pract. 23: 37–38 (1969).PubMedGoogle Scholar
  13. 13.
    Beghi, E., NIcoLosI, A., Kurland, L. T., Mulder, D. W., Hauser, W. A., And Shuster, L., Encephalitis and aseptic meningitis. Olmstead County, Minnesota, 1950–1981: 1. Epidemiology, Ann. Neurol. 16: 283–294 (1984).PubMedCrossRefGoogle Scholar
  14. 14.
    Bengtsson, E., And Orndahl, G., Complications of mumps with special reference to the incidence of myocarditis, Acta Med. Scand. 149: 381–388 (1954).PubMedCrossRefGoogle Scholar
  15. 15.
    Benito, R. J., Larrard, L., Lasierra, M. P., Benito, J. F., And Erdociain, E, Persistence of specific IgM antibodies after natural mumps infection, J. Infect. Dis. 155: 156–157 (1987).PubMedCrossRefGoogle Scholar
  16. 16.
    Bjorvatn, B., And Skoldenberg, B., Mumps, meningitis, and orchitis in Stockholm during 1955–1976: An epidemiological background for a vaccination policy, Lakartidningen 75: 2295–2298 (1978).Google Scholar
  17. 17.
    Bjorvatn, B., And Wolontis, S., Mumps meningoencephalitis in Stockholm November 1964-July 1971. 1. Analysis of a hospitalized study group. Questions of selection and representivity, Scand. J. Infect. Dis. 5: 253–260 (1973).Google Scholar
  18. 18.
    Black, E L., A nationwide serum survey of United States military recruits. 1962. Iii. Measles and mumps antibodies, Am. J. Hyg. 80: 304–307 (1964).PubMedCrossRefGoogle Scholar
  19. 19.
    Black, E L., Hierholzer, W. J. Dep., Pinheiro, E, Evans, A. S., Woodall, J. P., Upton, E. M., Emmons, J. E., West, B. E., Edsall, G., Downs, W. G., And Wallace, G. D., Evidence for persistence of infectious agents in isolated human populations, Am. J. Epidemiol. 100: 230–250 (1974).PubMedGoogle Scholar
  20. 20.
    Black, E L., And Houghton, W. J., The significance of mumps hemagglutinin inhibition titers in normal populations, Am. J. Epidemiol. 85: 101–197 (1967).PubMedGoogle Scholar
  21. 21.
    Bowers, D., And Weatherhead, D. S. P., Mumps encephalitis, Can. Med. Assoc. J. 69: 49–55 (1953).PubMedGoogle Scholar
  22. 22.
    Bray, P. F., Mumps-A cause of hydrocephalus? Pediatrics 49: 446–449 (1972).PubMedGoogle Scholar
  23. 23.
    Brickman, A., And Brunell, P. A., Susceptibility of medical students to mumps: Comparison of serum neutralizing antibody and skin test, Pediatrics 48: 447–450 (1972).Google Scholar
  24. 24.
    Briss, P. A., Fehrs, L. J., Parker, R. A., Wright, P. E, Sannella, E. C., Hutcheson, R. H., And Schaffner, W., Sustained transmission of mumps in a highly vaccinated population: Assessment of primary vaccine failure and waning vaccine-induced immunity, J. Infect. Dis. 169: 77–82 (1994).PubMedCrossRefGoogle Scholar
  25. 25.
    Brooks, H., Epidemic parotitis as a military disease, Med. Clin. North Am. 2: 493–503 (1918).Google Scholar
  26. 26.
    Brown, E. G., Furesz, J., Dimock, K., Yarosh, W., And Contreras, G., Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients, Vaccine 9: 840–841 (1991).PubMedCrossRefGoogle Scholar
  27. 27.
    Brown, J. W., Kirkland, H. B., And Hein, G. E., Central nervous system involvement during mumps, Am. J. Med. Sci. 215: 434 441 (1948).Google Scholar
  28. 28.
    Brown, N. J., And Richman, S. J., Fatal mumps myocarditis in an 8-month-old child, Br. Med. J. 281: 356–357 (1980).PubMedCrossRefGoogle Scholar
  29. 29.
    Brunell, P. A., Brickman, A., O’Hare, D., And Steinberg, S., Ineffectiveness of isolation of patients as a method of preventing the spread of mumps: Failure of the mumps skin antigen to predict immune status, N. Engl. J. Med. 279: 1357–1361 (1968).PubMedCrossRefGoogle Scholar
  30. 30.
    Bruyn, H. B., Sexton, H. M., And Brainerd, H. D., Mumps meningoencephalitis: A clinical review of 119 cases with one death, Calif. Med. 86: 153–160 (1957).PubMedGoogle Scholar
  31. 31.
    Buynak, E. B., And Hilleman, M. R., Live attenuated mumps virus vaccine. 1. Vaccine development, Proc. Soc. Exp. Biol. Med. 123: 768–775 (1966).PubMedCrossRefGoogle Scholar
  32. 32.
    Buynak, E. B., Hilleman, M. R., Leagus, M. B., Whitman, J. E., JR., Weibel, R. E., And Stokes, J., JR., Jeryl Lynn strain live attenuated mumps virus vaccine. Influence of age, virus dose, lot, and -y-globulin administration on response, J.A.M.A. 203: 63–67 (1968).CrossRefGoogle Scholar
  33. 33.
    Buynak, E. B., Hilleman, M. R., Whitman, J. E., JR., Weibel, R. E., And Stokes, J., JR., Measurement and durability of antibody following Jeryl Lynn strain viral mumps vaccine, in: Vaccines against Viral and Rickettsia! Diseases of Man: Proceedings of The First International Conference on Vaccines Against Viral and Rickettsia! Diseases in Man (Washington, DC, November 711, 1966) (Scientific Publ. 147), pp. 440–442, Washington, DC, Pan American Health Organization (1967).Google Scholar
  34. 34.
    Carmody, L., Van Loon, F., And Zeitz, P. S., Mumps outbreak on Yavapai County, Arizona, Immunization Action News 1 (2): 2 (1994).Google Scholar
  35. 35.
    Centers For Disease Control, Immunization Practices Advisory Committee, Mumps vaccine, Morbid. Mortal. Week. Rep. 16: 430–431 (1967).Google Scholar
  36. 36.
    Centers For Disease Control, Immunization Practices Advisory Committee, Mumps vaccine, Morbid. Mortal. Week. Rep. 21 (Suppl.): 17–18 (1972).Google Scholar
  37. 37.
    Centers For Disease Control Mumps prevention: Recommendations of the Immunization Practices Advisory Committee (Acip), Morbid. Mortal. Week. Rep. 26: 393–394 (1977).Google Scholar
  38. 38.
    Centers For Disease Control, Mumps prevention: Recom mendations of the Immunization Practices Advisory Committee (Acip), Morbid. Mortal. Week Rep. 29:87–88, 93–94 (1980).Google Scholar
  39. 39.
    Genters For Disease Control, Mumps—United States, 1980–1983, Morbid. Mortal. Week. Rep. 32: 545–547 (1983)Google Scholar
  40. 40.
    Centers For Disease Control, Mumps-United States, 1980–1983, Morbid. Mortal. Week Rep. 32: 545–547 (1983).Google Scholar
  41. 41.
    Centers For Disease Control, Mumps outbreak-New Jersey, Morbid. Mortal. Week. Resp. 33: 421–430 (1984).Google Scholar
  42. 42.
    Centers For Disease Control, Mumps outbreaks in university campuses-Illinois, Wisconsin, South Dakota, Morbid. Mortal. Week Rep. 36: 496–498 (1987).Google Scholar
  43. 43.
    Centers For Disease Control, Mumps-United States, 1985–1988, Morbid. Mortal. Week. Rep. 38: 101–105 (1989).Google Scholar
  44. 44.
    Centers For Disease Control, Mumps prevention: Recommendations of the Immunization Practices Advisory Committee (Acip), Morbid. Mortal. Week. Rep. 38: 388–392, 397–400 (1989).Google Scholar
  45. 45.
    Chaiken, B. P., Williams, N. M., Preblud, S. T., Parkin, W., And Altman, R., The effect of a school entry law on mumps activity in a school district, J.A.M.A. 257: 2455–2458 (1987).PubMedCrossRefGoogle Scholar
  46. 46.
    Chiba, Y., Horino, K., Umetsu, M., Wataya, Y., Chiba, S., And Nakao, T., Virus excretion and antibody responses in saliva in natural mumps, Tohoku J. Exp. Med. 111: 229–238 (1973).PubMedCrossRefGoogle Scholar
  47. 47.
    Chou, S. M., Inclusion body myositis: A chronic persistent mumps myositis? Human Pathol. 17: 765–777 (1986).CrossRefGoogle Scholar
  48. 48.
    Christenson, B., And Bottiger, M., Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus, Biologicals 18: 213–219 (1990).PubMedCrossRefGoogle Scholar
  49. 49.
    Cochi, S. L., Preblud, S. R., And Orenstein, W. A., Perspectives on the relative resurgence of mumps in the United States, Am. J. Dis. Child. 142: 499–507 (1988).PubMedGoogle Scholar
  50. 50.
    Cochi, S. L., Wharton, M., And Plotkin, S. A., Mumps vaccine, in: Vaccines (S. A. Plotkin And E. A. Mortimer, JR., Eds.), pp. 277–301, Saunders, Philadelphia, 1994.Google Scholar
  51. 51.
    Cooney, M. K., Fox, J. P, And Hall, C. E., The Seattle virus watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and mycoplasma pneumonia, Am. J. Epidemiol. 202: 532–551 (1975).Google Scholar
  52. 52.
    Cox, M. J., Anderson, R. M., Bundy, D. A. P., Nokes, D. J., And Didier, J. M., Seroepidemiological study of the transmission of the mumps virus in St. Lucia, West Indies, Epidemiol. Infect. 102: 147–160 (1989).PubMedCrossRefGoogle Scholar
  53. 53.
    Dacon-Voutetakis, C., Constantinidis, M., Moschos, A., Vlachon, C., And Matsaniotis, N., Diabetes mellitus following mumps: Insulin reserve, Am. J. Dis. Child. 127: 890–891 (1974).Google Scholar
  54. 54.
    Davidson, W. L., Buynak, E. B., Leagus, M. B., Whitman, J. E., JR., And Hillman, M. R., Vaccination of adults with live attenuated mumps virus vaccine, J.A.M.A. 201: 995–998 (1967).PubMedCrossRefGoogle Scholar
  55. 55.
    Davis, L. E., And Johnson, R. T., Experimental viral infection of the inner ear. I. Acute infections of the newborn hamster labrynth, Lab. Invest. 34: 349–356 (1976).PubMedGoogle Scholar
  56. 56.
    Deibel, R., And Schryver, G. D., Viral antibody in the cerebrospinal fluid of patients with acute central nervous system infections, J. Clin. Microbiol. 3: 397–401 (1976).PubMedGoogle Scholar
  57. 57.
    Duc-Nguyen, H., And Henle, W., Replication of mumps virus in human leukocyte cultures, J. Bacteriol. 92: 258–265 (1966).Google Scholar
  58. 58.
    Editorial, Mumps of the heart, Br. Med. J. 5481: 187–188 (1966).Google Scholar
  59. 59.
    Editorial, Mumps and the endocardium, N. Engl. J. Med. 275: 393 (1966).Google Scholar
  60. 60.
    Elango, N., The mumps virus nucleocapsid mRna sequence and homology among the paramyxoviridae proteins, Virus Res. 12: 77–86 (1989).PubMedCrossRefGoogle Scholar
  61. 60.
    Elango, N., Complete nucleotide sequence of the matrix protein mRna of mumps virus, Virology 168: 426–428 (1989).PubMedCrossRefGoogle Scholar
  62. 61.
    Elango, N., KmiameÉs, J., And Norrby, E., Sequence analysis of the mumps virus mRna encoding the P protein, Virology 169: 62–67 (1989).PubMedCrossRefGoogle Scholar
  63. 62.
    Elango, N., Varsanyi, T. M., Kovamees, J., And Norrby, E., The mumps virus fusion protein mRna sequence and homology among the Paramyxoviridae proteins, J. Gen. Viral. 70: 801–807 (1989).CrossRefGoogle Scholar
  64. 63.
    Enders, J. E, Techniques of laboratory diagnosis, tests for susceptibility, and experiments on specific prophylaxis, J. Pediatr. 29: 129–142 (1946).PubMedCrossRefGoogle Scholar
  65. 64.
    Enders, J. E, Levens, J. H., Stokes, J., JR., Maris, E. P., And Berenberg, W., Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg, J. Immunol. 54: 283–291 (1946).PubMedGoogle Scholar
  66. 65.
    Ennis, E A., Immunity to mumps in an institutional epidemic: Correlation of unsusceptibility to mumps with serum plaque neutralizing and hemagglutination-inhibiting antibodies, J. Infect. Dis. 119: 654–657 (1969).PubMedCrossRefGoogle Scholar
  67. 66.
    Ennis, F. A., And Jackson, D., Isolation of virus during the incubation period of mumps infection, J. Pediatr. 72: 536–537 (1968).PubMedCrossRefGoogle Scholar
  68. 67.
    Everberg, G., Deafness following mumps, Acta Otolaryngol. 48: 397–403 (1957).PubMedCrossRefGoogle Scholar
  69. 68.
    Eyland, E., Zmucky, R., And Sheba, C., Mumps virus and subacute thyroiditis: Evidence of a causal association, Lancet 1: 1062–1065 (1957).CrossRefGoogle Scholar
  70. 69.
    Falk, W. A., Buchan, K., Dow, M., Garson, J. Z., Hill, E., Nosal, M., Tarrant, M., Westbury, R. C., And White, E M. M., The epidemiology of mumps in Southern Alberta, 19801982, Am. J. Epidemiol. 130: 736–749 (1989).PubMedGoogle Scholar
  71. 70.
    Faoagali, J. L., An assessment of the need for vaccination amongst junior medical staff, N. Z. Med. J. 84: 147–150 (1976).PubMedGoogle Scholar
  72. 71.
    Feldstein, J. D., Johnson, E R., Kallick, C. A., And Doolas, A., Acute hemorrhagic pancreatitis and pseudocyst due to mumps, Ann. Surg. 180: 85–88 (1974).PubMedCrossRefGoogle Scholar
  73. 72.
    Fleisher, B., And Kreth, H. W., Mumps virus replication in human lymphoid cell lines and in peripheral blood lymphocytes: Preference for T cells, Infect. Immun. 35: 25–31 (1982).Google Scholar
  74. 73.
    Florman, A. L., Schick, B., And Scalettar, H. E., Placental transmission of mumps and streptococcus MG antibodies, Proc. Soc. Exp. Biol. Med. 78: 126–128 (1951).PubMedCrossRefGoogle Scholar
  75. 74.
    Fowler, E. R., Deafness in mumps, Pediatrics 77: 243–245 (1960).Google Scholar
  76. 75.
    Foy, H. M., Cooney, K. M., Hall, C. E., Bor, E., And Maletzky, A. J., Isolation of mumps virus from children with acute lower respiratory tract disease, Am. J. Epidemiol. 94: 467–472 (1971).PubMedGoogle Scholar
  77. 76.
    Frankland, A. W., Mumps meningo-encaphalitis, Br. Med. J. 2: 48–49 (1941).PubMedCrossRefGoogle Scholar
  78. 77.
    Freeman, A. G., Mumps followed by diabetes [letter to the editor], Lancet 2: 96 (1962).CrossRefGoogle Scholar
  79. 78.
    Freeman, R., And Hambling, M. H., Serological studies on 40 cases of mumps virus infection, J. Clin. Pathol. 33: 28–32 (1980).PubMedCrossRefGoogle Scholar
  80. 79.
    Friedman, M., Hadari, I., Goldstein, V., And Sarov, L., Virus-specific secretory IgA antibodies as means of rapid diagnosis of measles and mumps infection, Israel J. Med. Sci. 19:881–884 (1983).Google Scholar
  81. 80.
    Fryden, A., Link H., And Moller, E., Demonstration of Csf lymphocytes sensitized against mumps virus antigens in mumps meningitis, Acta Neurol. Scand. 57: 396–404 (1978).PubMedCrossRefGoogle Scholar
  82. 81.
    Fryden, A., Link, H., And Norrby, E., Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and in aseptic meningitis of other etiology, Infect. Immun. 21: 852–861 (1978).PubMedGoogle Scholar
  83. 82.
    Fryden, A., Link, H., And Norrby, E., Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and in aseptic meningitis of other etiology, Infect. Immun. 21: 852–861 (1978).PubMedGoogle Scholar
  84. 83.
    Gamble, D. R., Relationship of antecedent illness to the development of diabetes in children, Br. Med. J. 281: 99–101 (1980).PubMedCrossRefGoogle Scholar
  85. 84.
    Gamble, D. R., And Taylor, K. W., Seasonal incidence of diabetes mellitus, Br. Med. J. 3: 631–633 (1969).PubMedCrossRefGoogle Scholar
  86. 85.
    Garcia, A. G., Pereira, J. M., Vidigal, N., LoKato, Y. Y., Pegado, C. S., And Branco, J. P., Intrauterine infection with mumps virus, Obstet. Gynecol. 56: 756–759 (1980).Google Scholar
  87. 86.
    Gersony, W. M., Katz, S. L, And Nadas, A. S., Endocardial fibroelastosis and the mumps virus, Pediatrics 37: 430–434 (1966).PubMedGoogle Scholar
  88. 87.
    Ghosh, S., Guillain-Barre syndrome complicating mumps, Lancet 1: 895–896 (1967).PubMedCrossRefGoogle Scholar
  89. 88.
    Glick, D., An isolated case of mumps in a geriatric population, J. Am. Geriatr. Soc. 18: 642–644 (1970).PubMedGoogle Scholar
  90. 89.
    Gnann, J. W., JR., Meningitis and encephalitis caused by mumps virus, in: Infections of the Central Nervous System (W. M. Scheld, R. J. Whitley, And D. T. Durack, Eds.), pp. 113–125, Raven Press, New York, 1991.Google Scholar
  91. 90.
    Gordon, J. E., And Heeren, R. H., The epidemiology of mumps, Am. J. Med. Sci. 200: 412–428 (1940).Google Scholar
  92. 91.
    Gordon, J. E., And Kilham, L., Ten years in the epidemiology of mumps, Am. J. Med. Sci. 218: 338–359 (1949).PubMedCrossRefGoogle Scholar
  93. 92.
    Gordon, S. C., And Lauter, C. B., Mumps arthritis: A review of the literature, Rev. Infect. Dis. 6: 338–344 (1984).PubMedCrossRefGoogle Scholar
  94. 93.
    Graham, D. Y., Brown, C. H., Benrey, J., And Butel J. S., Thrombocytopenia: A complication of mumps, J.A.M.A. 227: 1161–1164 (1974).CrossRefGoogle Scholar
  95. 94.
    Greenberg, M. A., And Brix, D. L., Safe administration of mumps-measles-rubella vaccine in egg-allergic children, J. Pediatr. 113: 504–506 (1988).PubMedCrossRefGoogle Scholar
  96. 95.
    Grillner, L., And Blomberg, J., Hemolysis-in-gel and neutralization tests for determination of antibodies to mumps virus, J. Clin. Microbiol. 4: 11–15 (1976).PubMedGoogle Scholar
  97. 96.
    Gut, J. R, Spiess, C., Schmitt, S., And Kirn, A., Rapid diagnosis of acute mumps infection by a direct immunoglobulin M antibody capture enzyme inununoassay with labeled antigen, J. Clin. Microbiol. 21: 346–352 (1985).PubMedGoogle Scholar
  98. 97.
    Habel, K., Cultivation of mumps virus in the developing chick embryo and its application to studies of immunity to mumps in man, Public Health Rep. 60: 201–212 (1945).CrossRefGoogle Scholar
  99. 98.
    Habel, K., Preparation of mumps vaccine and immunization of monkeys against experimental mumps infection, Public Health Rep. 61: 1655–1664 (1946).PubMedCrossRefGoogle Scholar
  100. 99.
    Habel, K., Vaccination of human beings against mumps: Vaccine administered at the start of an epidemic. 1. Incidence and severity of mumps in vaccinated and control groups, Am. J. Hyg. 54: 295311 (1951).Google Scholar
  101. 100.
    Hall, R., And Richards, H., Hearing loss due to mumps, Arch. Dis. Child. 62: 189–191 (1987).PubMedCrossRefGoogle Scholar
  102. 101.
    Hamilton, R., An account of distemper by the common people of England vulgarly called the mumps, Land. Med. J. 11: 190–211 (1790).Google Scholar
  103. 102.
    Harmsen, T., Jongerius, M. C., Van Der Zwan, C. W., Plantinga, A. D., Kraaijeveld, C. A., And Berbers, G. A. M., Comparison of ä neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps, J. Clin. Microbiol. 30: 2139–2144 (1992).PubMedGoogle Scholar
  104. 102.
    Harris, R. W., Kehrer, A. F., And Isaacson, P., Relationship of occupation to risk of clinical mumps in adults, Am. J. Epidemiol. 89: 264–270 (1969).PubMedGoogle Scholar
  105. 103.
    Harris, R. W., Turnbeull, C. D., Isaacson, R. Karbon, D. T., And Winkelstein, W., JR., Mumps in a northeast metropolitan community. 1. Epidemiology of clinical mumps, Am. J. Epidemiol. 88: 224–233 (1968).Google Scholar
  106. 105.
    Hayashi, K., Ross, M. E., And Notkins, A. L., Persistence of mumps viral antigens in mouse brain, Jpn. J. Exp. Med. 46: 197–200 (1976).PubMedGoogle Scholar
  107. 106.
    Henderson, W., Mumps meningo-encephalitis: An outbreak in a preparatory school, Lancet 1: 386–388 (1952).PubMedCrossRefGoogle Scholar
  108. 107.
    Henle, G., Bashe, W. J., JR., Burgoon, J. S., Burgoon, C. E, Stokes, J., JR., And Henle, W., Studies on the prevention of mumps. Iii. The effect of subcutaneous injection of inactivated mumps virus vaccinees, J. Immunol. 66: 561–577 (1951).PubMedGoogle Scholar
  109. 108.
    Henle, G., Crawford, M. N., Henle, G., Tabio, H. F., Deinhardt, E, Chabau, A. G., And Olshin, I. J, Studies on the prevention of mumps. Vii. Evaluation of dosage schedules for inactivated mumps vaccine, J. Immunol. 83: 17–28 (1959).Google Scholar
  110. 109.
    Henle, G., And Dienhardt, E, Propagation and primary isolation of mumps virus in tissue culture, Proc. Soc. Exp. Biol. Med. 89: 556–560 (1955).PubMedCrossRefGoogle Scholar
  111. 110.
    Henle, G., Dienhardt, F., Bergs, V. V., And Henle, W., Studies on persistent infections in tissue culture. I. General aspects of the system, J. Exp. Med. 108: 537–560 (1958).PubMedCrossRefGoogle Scholar
  112. 111.
    Henle, G., Henle, W., Burgoon, J. S., Bashe, W. J., JR., And Stokes, J., JR., Studies on the prevention of mumps. I. The determination of susceptibility, J. Immunol. 66: 535–549 (1951).PubMedGoogle Scholar
  113. 112.
    Henle, G., Henle, W., Wendell, K. K., And Rosenberg, R, Isolation of mumps virus from human beings with induced appar- ent or inapparent infections, J. Exp. Med. 88: 223–232 (1948).PubMedCrossRefGoogle Scholar
  114. 113.
    Henle, G., And Mcdougall, C. L., Mumps meningoencephalitis: Isolation in chick embryos of virus from spinal fluid of a patient, Proc. Soc. Exp. Biol. Med. 66: 209–211 (1957).Google Scholar
  115. 114.
    Henle, G., Stokes, J., JR., Burgoon, J. S., Bashe, W. J., JR., Burgoon, C. F., And Henle, W., Studies on the prevention of mumps. IV. The effect of oral spraying of attenuated active virus, J. Immunol. 66: 579–594 (1951).PubMedGoogle Scholar
  116. 115.
    Herrler, G., And Compans, R. W., Synthesis of mumps polypeptides in infected Vero cells, Virology 119: 430–438 (1982).PubMedCrossRefGoogle Scholar
  117. 116.
    Hersh, B. S., Fine, E E., Kent, W. K., Cochi, S. L., Kahn, L. H., Zell, E. R., Hays, P. L., And Wood, C. L., Mumps outbreak in a highly vaccinated population, J. Pediatr. 119: 187–193 (1991).PubMedCrossRefGoogle Scholar
  118. 117.
    Hierholzer, J. C., And Farris, W. A., Follow-up of children infected in a coxsackievirus B-3 and B-4 outbreak: No evidence of diabetes mellitus, J. Infect. Dis. 129: 741–746 (1974).PubMedCrossRefGoogle Scholar
  119. 118.
    Hildes, J. A., Wilt, J. C., Parker, W. L., Stackiw, W., And Delaat, S., Surveys of respiratory virus antibodies in an Artie Indian population, Can. Med. Assoc. J. 93: 1015–1018 (1965).PubMedGoogle Scholar
  120. 119.
    Hilleman, M. R., Advances in control of viral infections by nonspecific measures and by vaccines, with special reference to live mumps and rubella virus vaccines, Clin. Pharmacol. Ther. 7: 752–762 (1966).PubMedGoogle Scholar
  121. 120.
    Hilleman, M. R., Weibel, R. E., Buynak, E. B., Stokes, J., JR., And Whitman, J. E., JR., Live, attenuated mumps-virus vaccine. 4. Protective efficacy as measured in a field evaluation, N. Engl. J. Med. 276: 252–258 (1968).CrossRefGoogle Scholar
  122. 121.
    Hinden, E., Mumps followed by diabetes, Lancet 1: 1381 (1962).PubMedCrossRefGoogle Scholar
  123. 122.
    Holden, E. M., Eagles, A. Y., And Stevens, J. E., Mumps involvement of the central nervous system, J.A.M.A. 131: 382385 (1946).Google Scholar
  124. 123.
    Hope Simpson, R. E., Infectiousness of communicable diseases in the household, Lancet 2: 549–554 (1952).CrossRefGoogle Scholar
  125. 125.
    Hughes, W. T., Steigman, A. J., And Delon, H. F., Some implications of fatal nephritis associated with mumps, Am. J. Dis. Child. 111: 297–301 (1966).PubMedGoogle Scholar
  126. 126.
    Huppertz, H-I., And Chantler, J. K., Restricted mumps virus infection of cells derived from normal human joint tissue, J. Gen. Virol. 72: 339–347 (1991).PubMedCrossRefGoogle Scholar
  127. 127.
    Huppertz, H-I., Niko, N. R. H., And Chantler, J. K., Susceptibility of normal human joint tissue to viruses, J. Rheumatol. 18: 699–704 (1991).PubMedGoogle Scholar
  128. 128.
    HYÖTY H., Leinikki, R, Reunanen, A., Ilonen, J., Surcel, H-M., Rilva, A., Kaar, M-L., Huupponen, T., Hakulinen, A., MÄKelÄ, A-L., And Akerblom, H. K., Mumps infections in the etiology of type 1 (insulin-dependent) diabetes, Diabetes Res. 9: 111–116 (1988).PubMedGoogle Scholar
  129. 129.
    Ilonen, J., Lymphocyte blast formation response of seropositive and seronegative subjects to herpes simplex, rubella, mumps, and measles virus antigens, Acta Pathol. Microbiol. Scand. 87: 151157 (1979).Google Scholar
  130. 130.
    Institute OF Medicine, Adverse Events Associated with Childhood Vaccines. Evidence Bearing on Causality (K. R. Stratton, C. J. Howe, And R. B. Johnston, JR., Eds.), pp. 118–186, National Academy Press, Washington, DC, 1994.Google Scholar
  131. 131.
    John, H. J., Diabetes mellitus in children: Review of 500 cases, J. Pediatr. 35: 723–744 (1949).PubMedCrossRefGoogle Scholar
  132. 132.
    Johnson, C. D., And Goodpasture, E. W., An investigation of the etiology of mumps, J. Exp. Med. 59: 1–19 (1934).PubMedCrossRefGoogle Scholar
  133. 133.
    Johnson, C. D., And Goodpasture, E. W., The etiology of mumps, Am. J. Hyg. 21: 46–57 (1935).Google Scholar
  134. 134.
    Johnstone, J. A., Ross, C. A. C., And DuNN, M., Meningitis and encephalitis associated with mumps infection. A 10-year survey, Arch. Dis. Child. 47: 647–651 (1972).PubMedCrossRefGoogle Scholar
  135. 135.
    Jones, A. G. H., White, J. M., And Begg, N. T., The impact of Mmr vaccine on mumps infection in England and Wales, Comm. Dis. Rep. 1: R93 - R96 (1991).Google Scholar
  136. 136.
    Jones, J. E, Ray, C. G., And Fulginiti, V. A., Perinatal mumps infection, J. Pediatr. 96: 912–914 (1980).PubMedCrossRefGoogle Scholar
  137. 137.
    Kahana, D., And Berant, M., Diabetes in an infant following inapparent mumps, Clin. Pediatr. 6: 124–125 (1967).CrossRefGoogle Scholar
  138. 138.
    Kalter, S. S., And Prier, J. E., Immunity to mumps among physicians, Am. J. Med. Sci. 229: 161–164 (1955).PubMedCrossRefGoogle Scholar
  139. 139.
    Kaplan, K. M., Marder, D. C., Cochi, S. L., And Preblud, S. R., Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease, J.A.M.A. 250: 1434–1438 (1988).CrossRefGoogle Scholar
  140. 140.
    Kaufman, J. J., And Bruce, P. T., Testicular atrophy following mumps: A cause of testis tumour? Br. J. Urol. 35: 65–69 (1963).CrossRefGoogle Scholar
  141. 141.
    Kelley, P. W., Petruccelli, B. R, Stehr-Green, P., Erickson, R. L., And Mason, C. J., The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits, J.A.M.A. 266: 2724–2729 (1991).Google Scholar
  142. 142.
    Kenny, 114 I. T., Jackson, J. E., Medler, E. M., Miller, S. A., And OsrioRN, R., Age-related immunity to measles, mumps and rubella in Middle American and United States children, Am. J. Epidemiol. 103: 174–180 (1976).Google Scholar
  143. 143.
    Kilham, L., Mumps meningoencephalitis with and without par-otitis, Am. J. Dis. Child. 78: 324–333 (1949).Google Scholar
  144. 144.
    Kilham, L., And Margolis, G., Intrauterine infections induced by mumps virus in hamsters, Lab. Invest. 31: 34–41 (1974).Google Scholar
  145. 144.
    King, R. C., Mumps followed by diabetes [letter to the editor], Lancet 2: 1055 (1962).CrossRefGoogle Scholar
  146. 145.
    Kirk, M., Sensorineural hearing loss and mumps, Br. J. Audiol. 21: 227–228 (1987).PubMedCrossRefGoogle Scholar
  147. 146.
    Kneeland, Y., JR., Mumps, in: Internal Medicine in World War II, Vol. II (J. B. Coates, JR., ED. IN Chief, W. P. Havens, JR., ED. For Internal Medicine), pp. 35–38, Office of the Surgeon General, Department of the Army, Washington, DC, 1963.Google Scholar
  148. 147.
    Koskiniemi, M. L., Donner, M., And Pettay, O., Clinical appearance and outcome of mumps encephalitis in children, Acta Paediatr. Scand. 72: 603–609 (1983).PubMedCrossRefGoogle Scholar
  149. 148.
    Koskiniemi, M., Manninen, V., Vaheri, A., Sainio, K., Eistola, O., And Karli, P., Acute encephalitis: A survey of epidemiological, clinical and microbiological features covering a twelve-year period, Acta Med. Scand. 209: 115–120 (1981).PubMedCrossRefGoogle Scholar
  150. 149.
    Koskiniemi, M. L., And Vaheri, A., Acute encephalitis of viral origin, Scand. J. Infect. Dis. 14: 181–187 (1982).PubMedGoogle Scholar
  151. 150.
    KÖVamees, J., Norrby, E., And Elango, N., Complete nucleotide sequence of the hemagglutinin-neuraminidase (HN) mRna of mumps virus and comparison of paramyxovirus HN proteins, Virus Res. 12: 87–96 (1989).PubMedCrossRefGoogle Scholar
  152. 151.
    Kravis, L. P., Sigel, M. M., And Henle, G., Mumps meningoencephalitis with special reference to the use of the complement fixation test in diagnosis, Pediatrics 8: 204–214 (1951).PubMedGoogle Scholar
  153. 152.
    Krugman, S., Muriel, G., And Fontana, V. J., Combined live measles, mumps, rubella vaccine: Immunological response, Am. J. Dis. Child. 121: 380–381 (1971).PubMedGoogle Scholar
  154. 153.
    Kurtz, J. B., Tomlinson, A. H., And Pearson, J., Mumps virus isolated from a fetus, Br. Med. J. 284: 471 (1982).CrossRefGoogle Scholar
  155. 154.
    Laurence, D., And Mcgavin, D., The complications of mumps, Br. Med. J. 1: 94–97 (1948).PubMedCrossRefGoogle Scholar
  156. 155.
    Leonidas, J. C., Athanasiades, T., And Zouboulakis, D., Mumps myocarditis: Case reports, J. Pediatr. 68: 650–653 (1966).CrossRefGoogle Scholar
  157. 156.
    Lennette, E. H., Jensen, F. W., Guenther, R. W., And Magoffin, R. L., Serologic responses to para-influenza viruses in patients with mumps virus infection,. Lab. Clin. Med. 61: 780–788 (1963).Google Scholar
  158. 157.
    Lennei IF., E. H., Magoffin, R. L., And Knoup, E. G., Viral central nervous system disease, J.A.M.A. 179: 687–695 (1962).CrossRefGoogle Scholar
  159. 158.
    Lepow, M. L., Carver, D. H., Wright, H. T., JR., Woods, W. A., And Robbins, E C., A clinical epidemiologic and laboratory investigation of aseptic meningitis during the four-year period. 1955–1958. I. Observations concerning etiology and epidemiology, N. Engl. J. Med. 266: 1181–1187 (1962).PubMedCrossRefGoogle Scholar
  160. 159.
    Levens, J. H., And Enders, J. F., The hemoagglutinative properties of amniotic fluid from embryonated eggs infected with mumps virus, Science 102: 117–129 (1945).PubMedCrossRefGoogle Scholar
  161. 160.
    Levitt, L. P, Mahoney, D. J., JR., Casey, H. L., And Bond, J. O., Mumps in a general population: A seroepidemiologic study, Am. J. Dis. Child. 120: 134–138 (1970).PubMedGoogle Scholar
  162. 161.
    Levitt, L. P., Rich, T. A., Kinde, S. W., Lewis, A. L., Gates, E. H., And Bond, J. O., Central nervous system mumps, Neurology 20: 829–834 (1970).PubMedCrossRefGoogle Scholar
  163. 162.
    Liao, S. J., And Benenson, A. S., Immunity status of military recruits in 1951 in the United States. II. Results of mumps complement-fixation tests, Am. J. Hyg. 59: 273–281 (1954).PubMedGoogle Scholar
  164. 163.
    Lightwood, R., Myelitis from mumps, Br. Med. J. 1: 484–485 (1946).CrossRefGoogle Scholar
  165. 164.
    Lin, C. Y, Chen, W. P., And Chiang, H., Mumps associated with nephritis, Child Nephrol. Urol. 10: 68–71 (1990).Google Scholar
  166. 166.
    Linde, G. A., Granstrom, M., And Orvell, C., Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity, J. Clin. Microbiol. 25: 1653–1658 (1987).PubMedGoogle Scholar
  167. 167.
    Lindsay, J. R., Davey, P. R., And Ward, P. H., Inner ear pathology in deafness due to mumps, Ann. Otol. Rhinol. Laryngol. 69: 918–935 (1960).PubMedGoogle Scholar
  168. 168.
    Link, H., Laurenzi, M. A., And Fryden, A., Viral antibodies in oligoclonal and polyclonal IgG synthesized with the central nervous system over the course of mumps meningitis, J. Neuroimmunol. 1: 287–298 (1981).PubMedCrossRefGoogle Scholar
  169. 169.
    Madden, D. L., FuccIllo, D. A., Traub, R. G., Ley, A. C., Sever, J. L., And Beadle, E. L., Juvenile onset diabetes mellitus in pregnant women: Failure to associate with coxsackie B1–6, mumps, or respiratory syncytial virus infections, J. Pediatr. 92: 959–960 (1978).PubMedCrossRefGoogle Scholar
  170. 170.
    Masson, A. M., And Nickerson, G. H., Mumps with nephritis, Can. Med. Assoc. 97: 866–867 (1967).Google Scholar
  171. 171.
    Maynard, J. E., Shramek, G., Noble, G. R., Deinhardt, F., And Clark, P, Use of attenuated live mumps virus vaccine during a “virgin soil” epidemic of mumps on St. Paul Island, Alaska, among US military recruits, Am. J. Epidemiol. 92: 301–306 (1970).PubMedGoogle Scholar
  172. 172.
    Mccarthy, M., And Johnson, R. T., A comparison of the structural polypeptides of five strains of mumps virus, J. Gen. Virol. 46: 15–27 (1980).PubMedCrossRefGoogle Scholar
  173. 173.
    Mccarthy, M., Wolinsky, J. S., And Lazzarini, R. A., A persistent infection of Vero cells by egg-adapted mumps virus, Virology 114: 343–356 (1981).PubMedCrossRefGoogle Scholar
  174. 174.
    Mccrae, W. M., Diabetes mellitus following mumps, Lancet 1: 1300–1301 (1963).CrossRefGoogle Scholar
  175. 175.
    Mcfarland, N. F., Pedone, C. A., Miagiali, E. S., And Mcfarlin, D. E., The response of human lymphocyte sub-populations to measles, mumps, and vaccinia viral antigens, J. Immunol. 125: 221–225 (1980).PubMedGoogle Scholar
  176. 176.
    Mcguinness, A. C., And Gall, E. A., Mumps at Army camps in 1943, War Med. 5: 95–104 (1944).Google Scholar
  177. 177.
    Mclean, D. M., Larke, R. P.13., Cobb, C., Griffis, E. D., And Hackett, S. M. R., Mumps and enteroviral meningitis in Toronto, 1966, Can. Med. Assoc. J. 96: 1355–1361 (1967).PubMedGoogle Scholar
  178. 178.
    Mclean, D. M., Walker, S. J., And Mcnaughton, G. A., Mumps meningoencephalitis: A virologic and clinical study, Can. Med. Assoc. J. 83: 148–151 (1960).PubMedGoogle Scholar
  179. 179.
    Messaritakis, J., Karabula, C., Kattamis, C., And Matsaniotis, N., Diabetes following mumps in sibs, Arch. Dis. Child. 46: 561–562 (1971).PubMedCrossRefGoogle Scholar
  180. 180.
    Meurman, O., HÄNninen, P., Krishna, R. V., And Ziegler, T., Determination of IgG- and IgM-class antibodies to mumps virus by solid-phase enzyme immunoassay, J. Virol. Methods 4: 249–257 (1982).PubMedCrossRefGoogle Scholar
  181. 181.
    Meyer, H. M., Johnson, R. T., Crawford, I. P., Dascomb, H. E., And Rogers, N. G., Central nervous system syndromes of “viral” etiology, Am. J. Med. 29: 334–347 (1960).PubMedCrossRefGoogle Scholar
  182. 182.
    Meyer, M. B., An epidemiologic study of mumps; its spread in schools and families, Am. J. Hyg. 75: 259–281 (1962).PubMedGoogle Scholar
  183. 183.
    Millar, J. H. D., Fraser, K. B., Haire, M., Connolly, J. H., Shirodaria, P. V., And Hadden, D. S. M., Immunoglobulin M. specific for measles and mumps in multiple sclerosis, Br. Med. J. 2: 378–380 (1971).PubMedCrossRefGoogle Scholar
  184. 183.
    Miller, E., Goldacre, M., Pugh, S., Colville, A., Far-Rington, P., Flower, A., Nash, J., Macfarlane, L., And Tettmar, R., Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children, Lancet 341: 979–982 (1993).PubMedCrossRefGoogle Scholar
  185. 184.
    Miller, H. G., Stanton, J. B., And Gibbons, J. L., Parainfectious encephalomyelitis and related syndromes, Q. J. Med. 25: 467–505 (1956).Google Scholar
  186. 185.
    Monteiro, G. E., And Lillicrap, C. A., Case of mumps nephritis, Br. Med. J. 4: 721–722 (1967).PubMedCrossRefGoogle Scholar
  187. 186.
    Moreland, A. E, Gaskin, J. M., Schimpff, R. D., Woodard, J. C., And Olson, G. A., Effects of influenza, mumps and western equine encephalitis virus on fetal rhesus monkeys, Teratology 20: 53–64 (1979).PubMedCrossRefGoogle Scholar
  188. 187.
    Morishima, T., Miyazu, M., Ogaki, T., Isomura, S., And Suzuki, S., Local immunity in mumps meningitis, Am. J. Dis. Child. 134: 1060–1064 (1980).PubMedGoogle Scholar
  189. 188.
    Morrison, J. C., Givens, J. R., And Wiser, W. L., Mumps oophoritis: A cause of premature menopause, Fertil. Steril. 26: 655–660 (1975).PubMedGoogle Scholar
  190. 189.
    Mufson, M. A., Parainfluenza viruses, mumps virus, Newcastle disease virus, in: Viral, Rickettsial and Chlamydial Infections, 6th Ed. (N. J. Schmidt And R. W. Emmons, Eds.), pp. 669–691, American Public Association, Washington, DC, 1989.Google Scholar
  191. 190.
    Narayan, K. M. V., And Moffat, M. A., Measles, mumps, rubella antibody surveillance: Pilot study in Grampian, Scotland, Health Bull. 50: 47–53 (1992).Google Scholar
  192. 191.
    Niederman, J. C., Henderson, J. R., Opton, E. M., Black, E. L., And Skvronova, K. A., A nationwide serum survey of Brazilian military recruits, 1964. II. Antibody patterns with arboviruses, polioviruses, measles and mumps, Am. J. Epidemiol. 86: 319–329 (1967).PubMedGoogle Scholar
  193. 192.
    Nokes, D. J., Wright, J., Morgan-Capner, E, And Anderson, R. M., Serological study of the epidemiology of mumps virus infection in north-west England, Epidemiol. Infect. 105: 175–195 (1990).PubMedCrossRefGoogle Scholar
  194. 193.
    Noren, G. R., Adams, E, JR., And Anderson, R. C., Positive skin reactivity to mumps virus antigen in endocardial fibroelastosis, J. Pediatr. 62: 604–606 (1963).PubMedCrossRefGoogle Scholar
  195. 194.
    Northrop, R. L., Effect of puromycin and actinomycin D on a persistent mumps virus infection in vitro, J. Virol. 4: 133–140 (1969).Google Scholar
  196. 195.
    Notkins, A. L., Virus-induced diabetes mellitus. Brief review, Arch. Virol. 54: 1–17 (1977).PubMedCrossRefGoogle Scholar
  197. 196.
    Oldfelt, V., Sequelae of mumps-meningoencephalitis, Acta Med. Scand. 134: 405–414 (1949).CrossRefGoogle Scholar
  198. 197.
    ÖRvell, C., Immunological properties of purified mumps virus glycoproteins, J. Gen. Virol. 41: 517–526 (1978).PubMedCrossRefGoogle Scholar
  199. 198.
    Orvell, C., The reactions of monoclonal antibodies with structural proteins of mumps virus, J. Immunol. 132: 2622–2699 (1984).PubMedGoogle Scholar
  200. 199.
    ÖRvell, C., Rydbeck, R., And Love, A., Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies, J. Gen. Virol. 67: 1929–1939 (1986).PubMedCrossRefGoogle Scholar
  201. 200.
    Overman, J. R., Viremia in human mumps virus infections, Arch. Intern. Med. 102: 354–356 (1958).CrossRefGoogle Scholar
  202. 201.
    Penttinen, K., Cantell, K., Somer, P., And Poikolainen, A., Mumps vaccination in the Finnish defense forces, Am. J. Epidemiol. 88: 234–244 (1968).PubMedGoogle Scholar
  203. 202.
    Philip, R. N., Reinhard, K. R., And Lackman, D. B., Observations on a mumps epidemic in a “virgin” population, Am. J. Hyg. 69: 91–111 (1959).PubMedGoogle Scholar
  204. 203.
    PosTovrr, V. A., Epidemic parotitis in adults, Voen. Med. Zh. 3: 38–41 (1983).Google Scholar
  205. 204.
    Prasad, L. N., Complete bilateral deafness following mumps, J. Laryngol. 77: 809–811 (1963).CrossRefGoogle Scholar
  206. 205.
    Prince, G. A., Jenson, A. B., Billups, L. C., And Notkins, A. L., Infection of human pancreatic beta cell cultures with mumps virus, Nature 271: 158–161 (1978).PubMedCrossRefGoogle Scholar
  207. 206.
    Reed, D., Brown, G., Merrick, R., Sever, J., And Feltz, E., A mumps epidemic on St. George Island, Alaska, J.A.M.A. 199: 967–971 (1967).CrossRefGoogle Scholar
  208. 207.
    Riffenburgh, R. S., Ocular manifestations of mumps, Arch. Ophthamol. 66: 739–743 (1961).CrossRefGoogle Scholar
  209. 208.
    Rima, B. K., Roberts, M. W., Mcadam, W. D., And Martin, S. J., Polypeptide synthesis in mumps virus-infected cells, J. Gen. Virol. 46: 501–505 (1980).PubMedCrossRefGoogle Scholar
  210. 209.
    Ritter, B. S., Mumps meningoencephalitis in children, J. Pediatr. 52: 424–432 (1958).PubMedCrossRefGoogle Scholar
  211. 210.
    Roberts, W. C., And Fox, S. M., Iii, Mumps of the heart: Clinical and pathologic features, Circulation 32: 342–345 (1965).PubMedCrossRefGoogle Scholar
  212. 211.
    Russell, R. R., And Donald, J. C., The neurological complications of mumps, Br. Med. J. 2: 27–30 (1958).PubMedCrossRefGoogle Scholar
  213. 212.
    Rydbeck, R., Love, A., ÖRvell, C., And Norrby, E., Antigenic variation of envelope and internal proteins of mumps virus strains detected with monoclonal antibodies, J. Gen. Virol. 67: 281–287 (1986).PubMedCrossRefGoogle Scholar
  214. 213.
    ST. Geme, J. W., J., Noren, G. R., And Adams, P., JR., Proposed embryopathic relation between mumps virus and primary endocardial fibroelastosis, N. Engl. J. Med. 275: 339–347 (1966).Google Scholar
  215. 214.
    ST. Geme, J. W., JR., Peralta, H., Farias, E., Davis, C. W. C., And Noren, G. R., Experimental gestional mumps virus infection and endocardial fibroelastosis, Pediatrics 48: 821–826 (1971).Google Scholar
  216. 215.
    Sakata, H., Tsurudome, M., Hishiyama, M., Ito, Y., And Sugiura, A., Enzyme-linked immunosorbent assay for mumps IgM antibody: Comparison of IgM capture and indirect IgM assay, J. Virol. Methods 12: 303–311 (1985).PubMedCrossRefGoogle Scholar
  217. 216.
    Samantray, S. K., Christopher, S., Mukundan, P., And Jonson, S. C., Lack of relationship between viruses and human diabetes mellitus, Aust. N. Z. J. Med. 7: 139–142 (1977).PubMedCrossRefGoogle Scholar
  218. 217.
    Scheid, W., Mumps virus and the central nervous system, World Neural. 2: 117–130 (1961).Google Scholar
  219. 218.
    Scherbaum, W. A., Hampl, W., Muir, E, GLÜCK, M., Seibler, J., Egle, H., Hauner, H., Boehm, B. O., Heinze, E., Banatvala, J. E., And Pfeiffer, E. E, No association between islet cell antibodies and coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7–19 years, Diabetologia 34: 835–838 (1991).PubMedCrossRefGoogle Scholar
  220. 219.
    Scully, C., Echersall, P. D., Edmond, R. T. D., Boyle, P., And Beeley, J A, Serum alpha-amylase isoenzyme in mumps: Estimation of salivary and pancreatic isoenzymes in isoelectric focusing, Clin. Chim. Acta 113: 281–291 (1981).PubMedCrossRefGoogle Scholar
  221. 220.
    Sever, J. L., And Kurtzke, J. F., Delayed dermal hypersensitivity to measles and mumps antigens among multiple sclerosis and control patients, Neurology 19: 113–115 (1969).Google Scholar
  222. 221.
    Server, A. C., Merz, D. C., Waxham, M. N., And Wolinsky, J. S., Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein, Infect. Immun. 35: 179–186 (1982).PubMedGoogle Scholar
  223. 222.
    Silverman, A. C., Mumps complicated by a preceding myelitis, N. Engl. J. Med. 241: 262–266 (1949).CrossRefGoogle Scholar
  224. 223.
    Sinha, S. K., And Carlson, S. D., Immune responses of mentally retarded subjects to measles, mumps and rubella vaccines, Wisc. Med. J. 74: S75 - S77 (1975).Google Scholar
  225. 224.
    Smith, G. A., And Guessen, R., Inner ear pathologic features following mumps infection: Report of a case in an adult, Arch. Otolaryngol. 102: 108–111 (1976).PubMedCrossRefGoogle Scholar
  226. 225.
    Smoak, B. L., Novakoski, W. L., Mason, C. J., And Erickson, R. L., Evidence for a recent decrease in measles susceptibility among young American adults, J. Infect. Dis. 170: 216–219 (1994).PubMedCrossRefGoogle Scholar
  227. 226.
    Smorodintsev, A. A., Luzianina, T. Y., And Mikutskaya, B. A., Data on the efficiency of live mumps vaccine from chick embryo cell cultures, Acta Virol. 9: 240–247 (1965).PubMedGoogle Scholar
  228. 227.
    Sosin, D. M., Cochi, S. L., Gunn, R. A., Jennings, C. E., And Preblud, S. R., Changing epidemiology of mumps and its impact on university campuses, Pediatrics 84: 779–784 (1989).PubMedGoogle Scholar
  229. 228.
    Sparling, D., Transmission of mumps (letter to the editor), N. Engl. J. Med. 280: 276 (1969).PubMedGoogle Scholar
  230. 229.
    Spataro, R. F., Lin, S. R., Hormer, F. A., Hall, C. B., And Mcdonald, J. V., Aqueductal stenosis and hydrocephalus: Rare sequelae of mumps virus infection, Neuroradiology 12: 11–13 (1976).Google Scholar
  231. 230.
    Stokes, J., JR., Mumps, in: Preventive Medicine in World War II, Vol. IV, Communicable Diseases Transmitted Chiefly Through Respiratory and Alimentary Tracts (prepared by the Historical Unit, U.S. Army Medical Service), pp. 135–140, US Government Printing Office, Washington, DC, 1958.Google Scholar
  232. 231.
    Stokes, J., JR., Weibel, R. E., Buynak, E. B., And Hilleman, M. R., Live attenuated mumps virus vaccine. II. Early clinical studies, Pediatrics 39: 363–371 (1967).PubMedGoogle Scholar
  233. 232.
    Struewing, J. P., Hyams, K. C., Tueller, J. E., And Gray, G. C., The risk of measles, mumps, and varicella among young adults: A serosurvey of US Navy and Marine Corps recruits, Am. J. Public Health 83: 1717–1729 (1993).PubMedCrossRefGoogle Scholar
  234. 233.
    Sugg, W. C., Finger, J. A., Levine, R. H., And Pagano, J. S., Field evaluation of live virus mumps vaccine, J. Pediatr. 72: 461–466 (1968).PubMedCrossRefGoogle Scholar
  235. 234.
    Sultz, H. A., Hart, B. A., Zickzny, M., Schlesinger, E. R., Is mumps virus an etiologic factor in juvenile diabetes mellitus? J. Pediatr. 86: 654–656 (1975).PubMedCrossRefGoogle Scholar
  236. 235.
    Swerdlow, A. J., HuTtly, S. R. A., And Smith, P. G., Testicular cancer and antecedent diseases, Br. J. Cancer 55: 97–103 (1987).PubMedCrossRefGoogle Scholar
  237. 236.
    Swierkosz, E. M., Mumps virus, in: Manual of Clinical Microbiology, 5th ed. (W. J. Hausler, JR., K. L. Herrmann, H. C. Isenberg, And H. J. Shadomy, Eds.), pp. 912–917, American Society for Microbiology, Washington, DC, 1991.Google Scholar
  238. 237.
    Thieme, T., Piacentini, S., Davidson, S., And Steingart, K., Determination of measles, mumps, and rubella immunization status using oral fluid samples, J.A.M.A. 272: 219–221 (1994).PubMedCrossRefGoogle Scholar
  239. 238.
    Timmoxs, G. D., And Johnson, K. P., Aqueductal stenosis and hydrocephalus after mumps encephalitis, N. Engl. J. Med. 283: 1505–1507 (1970).CrossRefGoogle Scholar
  240. 239.
    Thompson, J. A., Mumps: A case of acquired aqueductal steno-sis, J. Pediatr. 94: 923–924 (1979).PubMedCrossRefGoogle Scholar
  241. 240.
    Thompson, W. M., JR., And Nolan, T. B., Atrioventicular dissociation associated with Adams-Stokes syndrome presumably due to mumps myocarditis, J. Pediatr. 68: 601–607 (1966).CrossRefGoogle Scholar
  242. 241.
    Ukkonen, P., Granstrom, M. L., Rasanen, J., Salonen, E. M., And Penttinen, K., Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients, J. Med. Virol. 8: 257–265 (1981).PubMedCrossRefGoogle Scholar
  243. 242.
    Ukkonen, P., Vaisanen, O., And Penttinen, K., Enzyme-linked immunosorbent assay for mumps and parainfluenza type 1, immunoglobulin G, and immunoglobulin M antibodies, J. Clin. Microbiol. 11: 329–323 (1980).Google Scholar
  244. 243.
    Ukkonen, P., Vaisanen, O., And Penttinen, K., Enzyme-linked immunosorbent assay for mumps and parainfluenza type 1, immunoglobulin G, and immunoglobulin M antibodies, J. Clin. Microbiol. 11: 329–323 (1980).Google Scholar
  245. 244.
    Utz, J. P., Houx, V. N., And Alling, D. W., Clinical and laboratory studies of mumps. IV. Viruria and abnormal renal function, N. Engl. J. Med. 270: 1283–1286 (1964).PubMedCrossRefGoogle Scholar
  246. 245.
    Utz, J. P., And Szwed, C. F., Mumps. Iii. Comparison of methods for detection of viruria, Proc. Soc. Exp. Biol. Med. 110: 841–844 (1962).PubMedCrossRefGoogle Scholar
  247. 246.
    Utz, J. P., Szwed, C. F., And Kasel, J. A., Clinical and laboratory studies of mumps. II. Detection and duration of excretion of virus in urine, Proc. Soc. Exp. Biol. Med. 99: 259–261 (1958).PubMedCrossRefGoogle Scholar
  248. 247.
    Vaheri, A., Julkunen, I., And Koskiniemi, M. L., Chronic encephalomyelitis with specific increase in intrathecal mumps antibodies, Lancet 2: 685–688 (1982).PubMedCrossRefGoogle Scholar
  249. 248.
    Van Loon, F. P. L., Holmes, S. J., Sirotkin, B. I., Williams, W. W., Cochi, S. L., Hadler, S. C., And Lindegren, M. L., Mumps-United States, 1988–1993, Morbid. Mortal. Week. Rep. 44 (S5–3): 1–14 (1995).Google Scholar
  250. 249.
    Van Tiel, F. H., Kraaijeveld, C. A., Baller, J, Harmsen, T., Oostelaken, T. A. M., And Snippe, H., Enzyme immunoassay of mumps virus in cell culture with peroxidase-labelled virus specific monoclonal antibodies and its application for determination of antibodies, J. Virol. Methods 22: 99–108 (1988).PubMedCrossRefGoogle Scholar
  251. 250.
    Vandvik, B., Nilsen, R. E., Vartdal, E, And Norrby, E., Mumps meningitis: Specific and nonspecific antibody responses in the central nervous system, Acta Neurol. Scand. 65: 469–487 (1982).CrossRefGoogle Scholar
  252. 251.
    Vandvik, B., Norrby, E., Steen-Johnson, J., And Stensvold, K., Mumps meningitis: Prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid, Eur. Neurol. 17: 13–22 (1978).PubMedCrossRefGoogle Scholar
  253. 252.
    Vosburgh, J. B., Diehl, A. M., Liu, C., Lauer, R. M., And Fabiyi, A., Relationship of mumps to endocardial fibroelastosis: Complement-fixation, hemagglutination-inhibition and intradermal skin tests for mumps in children with and without endocardial fibroelastosis, Am. J. Dis. Child. 109: 69–73 (1965).PubMedGoogle Scholar
  254. 253.
    Vuori, M., Lahikainen, E. A., And Peltonen, T., Perceptive deafness in connection with mumps: A study of 298 servicemen suffering from mumps, Acta Otolaryngol. 55: 231–236 (1962).PubMedCrossRefGoogle Scholar
  255. 254.
    Wagenvoort, J. H. T., Harmsen, M., Boutahar-Trouw, B. J. K., Kraaijeveld, C. A., And Winkler, K. C., Epidemiology of mumps in the Netherlands, J. Hyg. 85: 313–326 (1980).PubMedCrossRefGoogle Scholar
  256. 255.
    Walker, D. L., And Hinze, H., A camer state of mumps virus in human conjunctiva cells. II. Observations on intracellular transfer of virus and virus release, J. Exp. Med. 116: 751–758 (1962).PubMedCrossRefGoogle Scholar
  257. 256.
    Waxham, M. N., Aronowski, J., Server, A. C., Wolinsky, J. S., Smith, J. A., And Goodman, H. M., Sequence determination of the mumps virus HN gene, Virology 164: 318–325 (1988).PubMedCrossRefGoogle Scholar
  258. 257.
    Waxham, M. N., Server, A. C., Goodman, H. M., And Wolinsky, J. S., Cloning and sequencing of the mumps virus fusion protein gene, Virology 159: 381–389 (1987).PubMedCrossRefGoogle Scholar
  259. 258.
    Weibel, R. E., Buynak, E. B., Mclean, A. A., And Hilleman, M. R., Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines, Pediatrics 61: 5–11 (1978).PubMedGoogle Scholar
  260. 258.
    Weibel, R. E., Buynak, E. B., Stokes, J., JR., Whitman, J. E., JR., And Hilleman, M. R., Evaluation of live attenuated mumps virus vaccine, strain Jeryl Lynn, in: Vaccines against Viral and Rickettsial Diseases of Man: Proceedings of the First International Conference on Vaccines against Viral and Rickettsial Diseases in Man (Washington, DC, November 7–11, 1966) (Scientific Publ. 147), pp. 430–437, Washington, DC, Pan American Health Organization (1967).Google Scholar
  261. 259.
    Weibel, R. E., Stokes, J., JR., Buynak, E. B., Leagus, M. B., And Hilleman, M. R., Durability of immunity following administration of Jeryl Lynn strain live attenuated mumps virus vaccine, J.A.M.A. 203: 14–18 (1968).PubMedCrossRefGoogle Scholar
  262. 260.
    Weibel, R. E., Stokes, J., JR., Buynak, E. B., Whitman, J., And Hilleman, M. R., Live attenuated mumps virus vaccine. 3. Clinical and serologic aspects in a field evaluation, N. Engl. J. Med. 276: 245–251 (1967).PubMedCrossRefGoogle Scholar
  263. 261.
    Weibel, R. E., Villarejos, V. M., Hernandez, C. G., Stokes, J., JR., Buynak, E. B., And Hilleman, M. R., Combined live measles-mumps virus vaccine, Arch. Dis. Child. 48: 532–536 (1973).PubMedCrossRefGoogle Scholar
  264. 262.
    Weller, T H, And Craig, J. R., Isolation of mumps virus at autopsy, Am. J. Pathol. 25: 1105–1115 (1949).PubMedGoogle Scholar
  265. 263.
    Werner, C. A., Mumps orchitis and testicular atrophy. I. Occurrence, Ann. Intern. Med. 32: 1066–1074 (1950).PubMedCrossRefGoogle Scholar
  266. 264.
    Werner, C. A., Mumps orchitis and testicular atrophy. II. A factor in male sterility, Ann. Inter. Med. 32: 1075–1086 (1950).CrossRefGoogle Scholar
  267. 265.
    Wesselhoeft, C., And Walcott, C. F., Mumps as a military disease and its control, War Med. 2: 213–222 (1942).Google Scholar
  268. 266.
    Westmore, G. A., Pickard, B. H., And Stern, H., Isolation of mumps virus from the inner ear after sudden deafness, Br. Med. J. 1: 14–15 (1979).PubMedCrossRefGoogle Scholar
  269. 267.
    Wharton, M., Cochi, S. L., Hutcheson, R. H., Bistowish, J. M., And Schaffner, W., A large outbreak of mumps in the postvaccine era, J. Infect. Dis. 158: 1253–1260 (1988).PubMedCrossRefGoogle Scholar
  270. 268.
    Wharton, M., Cochi, S. L., Hutcheson, R. W., And Schaffner, W., Mumps transmission in hospitals, Arch. Intern. Med. 150: 47–49 (1990).PubMedCrossRefGoogle Scholar
  271. 269.
    White, C. C., Koplan, J. R, And Orenstein, W. A., Benefits, risks and costs of immunization for measles, mumps, and rubella, Am. J. Public Health 75: 739–744 (1985).PubMedCrossRefGoogle Scholar
  272. 270.
    Wilfert, C. M., Mumps meningoencephalitis with low cerebrospinal-fluid glucose, prolonged pleocytosis and elevation of protein, N. Engl. J. Med. 280: 855–859 (1969).PubMedCrossRefGoogle Scholar
  273. 271.
    Wolinsky, J. S., Baringer, J. R., Margolis, G., And Kilham, L., Ultrastructure of mumps virus replication in newborn hamster central nervous system, Lab. Invest. 31: 402–412 (1974).Google Scholar
  274. 272.
    Wolinsky, J. S., Klassen, T., And Baringer, J. R., Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation, J. Infect. Dis. 133: 260–267 (1976).PubMedCrossRefGoogle Scholar
  275. 273.
    Wolinsky, J. S., And Waxham, M. N., Mumps virus, in: Virology (B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsh, J. L. Melnick, T. R. Monath, And B. Roizman, Eds.), pp. 989–1011, Raven Press, New York, 1990.Google Scholar
  276. 275.
    Wolontis, S., And Bhorvatn, B., Mumps meningoencephalitis in Stockholm, November 1964-July 1961. II. Isolation attempts for the cerebrospinal fluid in a hospitalized group, Scand. J. Infect. Dis. 5: 261–271 (1973).PubMedGoogle Scholar
  277. 276.
    Yamada, A., Takeuchi, K., Tanabayashi, K., Hishiyama, M., And Sugiura, A., Sequence variation of the p gene among mumps virus strains, Virology 172: 374–376 (1989).PubMedCrossRefGoogle Scholar
  278. 277.
    Yamada, A., Takeuchi, K., Tanabayashi, K., Hishiyama, M., Takahashi, Y., And Sugiura, A., Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene, Vaccine 8: 553–557 (1990).PubMedCrossRefGoogle Scholar
  279. 278.
    Yamauchi, T., Wilson, C., And ST. Geme, J. W., J., Transmission of live, attenuated mumps virus to the human placenta, N. Engl. J. Med. 290: 710–712 (1974).Google Scholar
  280. 279.
    Young, M. L., Dickstein, B., Weibel, R. E., Stokes, J., JR., Buynak, E. B., And Hillemman, M. R., Experience with Jeryl Lynn strain live attenuated mumps virus vaccine in pediatric outpatient clinic, Pediatrics 40: 798–803 (1967).PubMedGoogle Scholar
  281. Baum, S. G., And Litman, N., Mumps virus, in: Principles and Practices of Infectious Diseases, 4th ed. (G. L. Mandell, J. E. Bennett, And R. Dolin, Eds.), pp. 1496–1501, Churchill Livingstone, New York, 1995.Google Scholar
  282. Brunell, P. A., Mumps, in: Textbook of Infectious Diseases, 3rd ed. (J. D. Cherry And R. D. Feigin, Eds.), pp. 1610–1613, Saunders, Philadelphia, 1992.Google Scholar
  283. Cochi, S. L., Wharton, M., And Plotkin, S. A., Mumps vaccine, in: Vaccines (S. A. Plotkin And E. A. Mortimer, JR., Eds.), pp. 277–301, Saunders, Philadelphia, 1994.Google Scholar
  284. Gnann, J. W., JR., Meningitis and encephalitis caused by mumps virus, in: Infections of the Central Nervous System (W. M. Scheld, R. J. Whitley, And D. T. Durack, Eds.), pp. 113–125, Raven Press, New York, 1991.Google Scholar
  285. Gutierrez, K., Mumps virus, in: Pediatric Infectious Diseases (S. S. Long, L. K. Pickering, And C. G. Prober, Eds.), pp. 1242–1247, Churchill Livingstone, Inc., New York, 1997.Google Scholar
  286. Wolinsky, J. S., And Waxham, M. N., Mumps virus, in: Virology (B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsh, J. L. Melnick, T. R Monath, And B. Roizman, Eds.), pp. 989–1011, Raven Press, New York, 1990.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Sandra J. Holmes
    • 1
  1. 1.Center for Pediatric ResearchEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations